Despite challenging macroeconomic environment, Intuitive Surgical (ISRG US) reported stellar Q3 results, with revenue growing 11% y/y to $1.56 billion, mainly driven by da Vinci procedure growth of 20%.
Q3 procedure growth reflected U.S. and OUS procedures growth of 18% and 24%, respectively. Management has raised 2022 da Vinci procedure growth guidance to 17–18% from 14.0–16.5% earlier.
System placement improved 9% q/q to 305 placements, with system ASP remaining at $1.5 million, consistent with last quarter. As of 3Q22, installed base grew 13% y/y to 7,364 systems.
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.